Alpha 2.0
Login Register
» Articles » PMID: 36483363

Antibodies in Healthcare Personnel Following Severe Acute Respiratory Syndrome Coronavirus Virus 2 (SARS-CoV-2) Infection

Overview
Journal Antimicrob Steward Healthc Epidemiol
Publisher Cambridge University Press
Specialty Infectious Diseases
Date 2022 Dec 9
PMID 36483363
Authors
Rachel E Bosserman
Christopher W Farnsworth
Caroline A ONeil
Candice Cass
Daniel Park
Claire Ballman
Meghan A Wallace
Emily Struttmann
Henry Stewart
Olivia Arter
Kate Peacock
Victoria J Fraser
Philip J Budge
Margaret A Olsen
Carey-Ann D Burnham
Hilary M Babcock
Jennie H Kwon
Affiliations
Soon will be listed here.
Abstract

In a prospective cohort of healthcare personnel (HCP), we measured severe acute respiratory syndrome coronavirus virus 2 (SARS-CoV-2) nucleocapsid IgG antibodies after SARS-CoV-2 infection. Among 79 HCP, 68 (86%) were seropositive 14-28 days after their positive PCR test, and 54 (77%) of 70 were seropositive at the 70-180-day follow-up. Many seropositive HCP (95%) experienced an antibody decline by the second visit.

Citing Articles

SARS-CoV-2 anti-N antibodies among healthcare personnel without previous known COVID-19.

Tiwary S, ONeil C, Peacock K, Cass C, Amor M, Wallace M Antimicrob Steward Healthc Epidemiol. 2024; 4(1):e184.

PMID: 39450093 PMC: 11500274. DOI: 10.1017/ash.2024.389.

Seroprevalence of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) antibodies among healthcare personnel in the Midwestern United States, September 2020-April 2021.

Bosserman R, Farnsworth C, ONeil C, Cass C, Park D, Ballman C Antimicrob Steward Healthc Epidemiol. 2023; 3(1):e133.

PMID: 37592963 PMC: 10428156. DOI: 10.1017/ash.2022.375.

References
1.
Wellinghausen N, Plonne D, Voss M, Ivanova R, Frodl R, Deininger S . SARS-CoV-2-IgG response is different in COVID-19 outpatients and asymptomatic contact persons. J Clin Virol. 2020; 130:104542. PMC: 7336915. DOI: 10.1016/j.jcv.2020.104542. View
2.
Sudre C, Murray B, Varsavsky T, Graham M, Penfold R, Bowyer R . Attributes and predictors of long COVID. Nat Med. 2021; 27(4):626-631. PMC: 7611399. DOI: 10.1038/s41591-021-01292-y. View
3.
Young B, Ong S, Ng L, Anderson D, Chia W, Chia P . Viral Dynamics and Immune Correlates of Coronavirus Disease 2019 (COVID-19) Severity. Clin Infect Dis. 2020; 73(9):e2932-e2942. PMC: 7499509. DOI: 10.1093/cid/ciaa1280. View
4.
Khoury D, Cromer D, Reynaldi A, Schlub T, Wheatley A, Juno J . Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection. Nat Med. 2021; 27(7):1205-1211. DOI: 10.1038/s41591-021-01377-8. View
5.
Magleby R, Westblade L, Trzebucki A, Simon M, Rajan M, Park J . Impact of Severe Acute Respiratory Syndrome Coronavirus 2 Viral Load on Risk of Intubation and Mortality Among Hospitalized Patients With Coronavirus Disease 2019. Clin Infect Dis. 2020; 73(11):e4197-e4205. PMC: 7337625. DOI: 10.1093/cid/ciaa851. View